Debra Arlene Feaks is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of medical technology, particularly in the area of boron neutron capture therapy. With a total of 2 patents, her work focuses on innovative methods for delivering boron to mammalian tissue, which has the potential to enhance cancer treatment.

Latest Patents

Her latest patents include "Methods for boron delivery to mammalian tissue" and "Compositions for boron delivery to mammalian tissue." The first patent outlines a treatment modality that utilizes boron neutron capture therapy to destroy tumors. This method is enhanced by delivering compounds to the tumor site, where they achieve high concentrations of boron. The boron compounds are encapsulated in liposomes, which can increase tumor specificity. The second patent describes the use of borane salts, which may be used free or encapsulated in liposomes, to improve the delivery of boron to targeted tissues.

Career Highlights

Debra is affiliated with the University of California, where she continues her research and development in this innovative field. Her work has the potential to significantly impact cancer treatment methodologies and improve patient outcomes.

Collaborations

She has collaborated with notable colleagues, including Marion Frederick Hawthorne and Kenneth John Shelly, to advance her research and explore new avenues in boron delivery systems.

Conclusion

Debra Arlene Feaks is a trailblazer in the field of boron neutron capture therapy, with her innovative patents paving the way for advancements in cancer treatment. Her contributions to medical technology are invaluable and continue to inspire future research.